Nasdaq

Medtronic Introduces MiniMed™ Mio™ Advance Infusion Set Enabling Fewer Insertion Steps for People with Diabetes in the U.S.

DUBLIN, July 07, 2020 (GLOBE NEWSWIRE) -- Medtronic plc (NYSE:MDT), the global leader in medical technology, today introduced the MiniMed™ Mio™ Advance infusion set to all Medtronic insulin pump ...
Diabetes.co.uk

Minimed Mio Advance Infusion Set launched to make pump insertion easier

A device designed to make inserting insulin pump infusion sets easier has been made available in Europe. The MiniMed Mio Advance Infusion Set, unveiled at a recent diabetes conference in Vienna, comes ...
Healio

Extended-wear insulin infusion set lasts 7 days for most wearers, with few adverse events

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. A novel extended-wear insulin infusion set was usable ...
FierceBiotech

FDA clears BD insulin infusion set developed with diabetes patient advocacy groups

Becton Dickinson ($BDX) worked with diabetes patient advocate groups to develop its latest insulin infusion set, which is designed for improved insulin flow with ...
FierceBiotech

Medtronic begins US launch of 7-day insulin infusion set

The thin plastic tubing of infusion sets that connect insulin pumps to the body typically need to be changed every two or three days—but a new version in the U.S. more than doubles that timespan. The ...
Los Angeles Business Journal

Promising Clinical Feasibility Results for Seven-Day-Wear Infusion Set Technology Announced

Medical device developer Capillary Biomedical, Inc. (CapBio) has presented highly favorable clinical feasibility study results for its SteadiFlow cannula technology at this year’s American Diabetes ...
TCTMD

Medtronic Begins Initial European Market Launch of World's First Combined Glucose Sensor and Insulin Infusion Set for People with Diabetes

TOLOCHENAZ, SWITZERLAND - Medtronic, Inc. today announced the European launch of MiniMed® Duo(TM), the world's first two-in-one breakthrough that combines a glucose sensor and insulin infusion set ...
Business Wire

Capillary Biomedical Reports Best-in-Class Clinical Feasibility Results for its SteadiFlow Seven-Day-Wear Infusion Set Technology at ADA Scientific Sessions

IRVINE, Calif.--(BUSINESS WIRE)--Medical device developer Capillary Biomedical, Inc. (CapBio) has presented highly favorable clinical feasibility study results for its SteadiFlow cannula technology at ...